|
Volumn 12, Issue 1, 2001, Pages 61-67
|
Charges in the use of medications after acute mycardial infarction: Possible impact on mortality after myocardial infarction and long-term outcome
a a a a a a a a |
Author keywords
Medication; Myocardial infarction; Prognosis; Risk indicators
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTIARRHYTHMIC AGENT;
ANTICOAGULANT AGENT;
ANTILIPEMIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM ANTAGONIST;
DIGITALIS;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
FIBRINOLYTIC AGENT;
NITRIC ACID DERIVATIVE;
PSYCHOTROPIC AGENT;
ANTITHROMBOCYTIC AGENT;
ACUTE HEART INFARCTION;
ADULT;
AGED;
ARTICLE;
CONGESTIVE HEART FAILURE;
DRUG USE;
FEMALE;
HOSPITAL DISCHARGE;
HUMAN;
MALE;
MORTALITY;
PRESCRIPTION;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
RISK ASSESSMENT;
SURVIVAL RATE;
TREATMENT OUTCOME;
HEART INFARCTION;
MIDDLE AGED;
PROGNOSIS;
SWEDEN;
ADULT;
AGED;
AGED, 80 AND OVER;
ASPIRIN;
FEMALE;
FIBRINOLYTIC AGENTS;
HUMANS;
MALE;
MIDDLE AGED;
MYOCARDIAL INFARCTION;
PLATELET AGGREGATION INHIBITORS;
PROGNOSIS;
RISK ASSESSMENT;
SWEDEN;
|
EID: 0034746365
PISSN: 09546928
EISSN: None
Source Type: Journal
DOI: 10.1097/00019501-200102000-00009 Document Type: Article |
Times cited : (6)
|
References (16)
|